Page last updated: 2024-08-24

ranitidine bismuth citrate and clarithromycin

ranitidine bismuth citrate has been researched along with clarithromycin in 93 studies

Research

Studies (93)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's39 (41.94)18.2507
2000's50 (53.76)29.6817
2010's3 (3.23)24.3611
2020's1 (1.08)2.80

Authors

AuthorsStudies
Ciociola, AA; McSorley, DJ; Peterson, WL; Sykes, DL; Webb, DD1
Webb, DD1
Axon, AT; Ireland, A; Rooprams, PD; Smith, MJ1
Bardhan, KD; Dallaire, C; Duggan, AE; Eisold, H1
Bisso, G; Caroli, M; Celle, G; Mansi, C; Mela, GS; Mele, MR; Olivieri, A; Saggioro, A; Savarino, V; Termini, R; Tosatto, R; Vigneri, S1
Hamilton, MR; Pounder, RE; Sercombe, JC; Williams, MP1
Donnelly, C; McDowell, S; McLaren, A; Williamson, R1
Dixon, JS; Mills, JG; Pipkin, GA; Wood, JR1
Fennerty, MB1
Pipkin, GA; Williamson, R; Wood, JR2
Bardhan, KD; Jahnsen, J; Lotay, N; Marcelino, M; Roberts, PM; Wurzer, H1
Scheen, AJ1
Bazzoli, F; Cardelli, A; Catalano, FA; Giglio, A; Lami, F; Olivieri, A; Pilotto, A; Pozzato, P; Roda, E; Scarpulla, G; Spadaccini, A; Susi, D; Tosatto, R; Zagari, M1
Crobach, LF; Geraedts, AA; Kolkman, JJ; Nicolai, JJ; Oudkerk Pool, M; Tan, TG; Timmerman, RJ; Van Der Laan, J; Van Kleef, WA; Wolff, AA1
de Boer, WA; Haeck, PW; Mulder, CJ; Otten, MH1
Bazzoli, F; Cannizzaro, O; D'Angelo, A; Ederle, A; Fossi, S; Gerace, G; Iaquinto, G; Olivieri, A; Pozzato, P; Reina, G; Ricciardiello, L; Roda, E; Scarpulla, G; Spadaccini, A; Tosatto, R; Zagari, M1
Armuzzi, A; Cammarota, G; Cannizzaro, O; Cianei, R; Cuoco, L; Fedeli, G; Fedeli, P; Gasbarrini, A; Gasbarrini, G; Papa, A; Tursi, A1
Bentivegna, C; Brogna, A; Catalano, F; Catanzaro, R; Cipolla, R; Condorelli, G1
Di Matteo, G; Dobrilla, G; Dodero, M; Fina, P; Fratton, A; Iaquinto, G; Loriga, P; Marchi, S; Marzio, L; Muratori, R; Olivieri, A; Pacini, D; Saggioro, A; Savarino, V; Spinelli, P; Tosatto, R; Zamboni, G1
Kleibeuker, JH; Kooy, A; Thijs, JC; van der Wouden, EJ; van Zwet, AA1
Chan, FK; Cheng, AF; Chung, SC; Lee, YT; Leung, WK; Ling, TK; Sung, JJ; Yung, MY1
Ciociola, AA; Heath, A; Lanza, FL; McSorley, DJ; Sontag, SJ; Sykes, DL1
Bardhan, KD; Duggan, AE; Gudjonsson, H; Hoie, O; Kliebe-Frisch, C; Kristensen, ES; Pipkin, GA; Schuetz, E1
Biagini, R; Bilardi, C; Bisso, G; Celle, G; Mansi, C; Mele, MR; Pivari, M; Savarino, V; Termini, R; Vigneri, S; Zentilin, P1
Anderson, SY; El-Zimaity, HM; Graham, DY; Hoffman, J; Osato, MS; Qureshi, W1
Kleibeuker, JH; Kooy, A; Thijs, JC; Van der Wouden, EJ; Zwet, AA1
Ashktorab, H; Hinds, T; Jagtap, J; Kim, KS; Scott, VF; Smoot, DT1
Cave, DR; Hoffman, JS; Katz, LM1
Cutler, A; Vakil, N1
McSorley, DJ; Perschy, TB; Schwartz, HI; Sorrells, SC1
Cross, R; Grimley, CE; Illing, RC; Lismore, JR; Loft, DE; Nwokolo, CU; O'sullivan, M; Penny, A; Shebani, M1
Bardhan, KD; Farley, A; French, PC; Paré, P; Roberts, PM; Romãozinho, JM1
Chan, FK; Cheng, AF; Chung, SC; Lee, YT; Leung, WK; Ling, TK; Suen, R; Sung, JJ; Wu, JC1
Dagalp, K; Kadayifci, A; Kilinc, R; Uygun, A1
Carpio, D; Gisbert, JL; Gisbert, JP; Grávalos, RG; Marcos, S; Pajares, JM1
Kerr, TG; Lambert, JR; Midolo, PD; Tee, W1
Armuzzi, A; Cammarota, G; Cannizzaro, O; Cianci, R; Gasbarrini, A; Gasbarrini, G; Papa, A; Pastorelli, A1
Armuzzi, A; Cammarota, G; Cannizzaro, O; Cianci, R; Gasbarrini, A; Gasbarrini, G; Gentiloni, N; Ojetti, V; Pastorelli, A; Pirozzi, G1
Anti, M; Armuzzi, A; Branca, G; Candelli, M; Canducci, F; Fadda, G; Fedeli, G; Gasbarrini, A; Gasbarrini, G; Ojetti, V; Pastorelli, A; Pola, P; Torre, ES1
Chan, FK; Chung, SC; Ling, TK; Suen, R; Sung, JJ; Wu, JC1
Ballardini, G; Boni, F; Bortoli, A; Colombo, E; Minoli, G; Spinzi, GC; Venturelli, R1
Fox, JG; Marini, RP; McColm, AA; Taylor, NS; Williamson, R; Yan, L1
Bilardi, C; Bisso, G; Borgonovo, G; Borro, P; De Salvo, L; Dulbecco, P; Mansi, C; Pivari, M; Raffaella Mele, M; Savarino, V; Tessieri, L; Vigneri, S; Zentilin, P1
De Boer, WA; Jansen, JB; Van Oijen, AH; Verbeek, AL1
Calvet, X; Gabriel, R; Gisbert, JP; González, L; Pajares, JM; Roqué, M1
Buzás György, M; Illyés, G; Székely, E; Széles, I1
Bentivegna, C; Branciforte, G; Brogna, A; Catalano, F; Catanzaro, R; Cipolla, R1
Chiba, N1
Cabezudo, JG; Ducóns, J; Gomollon, F; Guirao, R; Montoro, M; Santolaria, S1
Mégraud, F; Roberts, P; Williamson, R1
Chan, CK; Chu, KM; Fung, FM; Hu, WH; Lai, KC; Lam, SK; Lau, GK; Leung, SY; Wang, WH; Wong, BC; Wong, WM; Yuen, MF; Yuen, ST1
De Boer, WA; Jansen, JB; Janssen, MJ; Van Oijen, AH; Verbeek, AL1
Chejfec, G; O'Connell, S; Schnell, T; Seidel, J; Sonnenberg, A; Sontag, SJ1
Belmonte, A; Cavaliere, C; Ciliberto, E; Fiocca, R; Frandina, C; Giglio, A; Luzza, F; Pallone, F; Saccà, N; Trimboli, V1
Andriulli, A; Annese, V; Niro, GA; Perri, F; Quitadamo, M; Villani, MR1
Hopkins, RJ1
Gisbert, JL; Gisbert, JP; Marcos, S; Pajares, JM2
Chiba, N; Hunt, RH; Thomson, AB1
Bardhan, KD; Mitchell, TR; Morris, P; Morton, D; Perry, MJ; Roberts, PM; Rowland, A; Sanders, DS; Thompson, M1
Bujanda, L; Cosme, A; Iriondo, C; Muñoz, C; Sánchez, A; Santos, A1
Beales, IL1
Doulgeroglou, V; Kamberoglou, D; Patra, E; Polymeros, D; Sanidas, I; Savva, S; Tzias, V1
De Francesco, V; Faleo, D; Hassan, C; Ierardi, E; Morini, S; Panella, C; Zullo, A1
Gisbert, JP; Pajares, JM1
Bago, J; Bevanda, M; Bilić, A; Halle, ZB; Jandrić, D; Kućisec, N; Strinić, D; Tomić, M1
Kullavanijaya, P; Tangkijvanich, P; Thong-Ngam, D; Treeprasertsuk, S; Wisedopas, N1
Farup, PG; Høie, O; Lange, OJ; Tholfsen, J; Torp, R; Wetternus, S1
Hopkins, RJ; Meyer, JM1
Chehter, EZ; Eisig, JN; Hashimoto, C; Laudanna, AA; Silva, FM1
Barkun, A; Chiba, N; Cockeram, A; Dallaire, C; Fallone, C; Farley, A; Nicholls, B; Simms, L; Veldhuyzen van Zanten, S1
Balatsinou, C; Caldarella, MP; Cuccurullo, F; Di Bonaventura, G; Lapenna, D; Laterza, F; Milano, A; Neri, M; Piccolomini, R1
Bianchi Porro, G; Cucino, C; Parente, F1
Candelli, M; Franceschi, F; Gasbarrini, G; Mettimano, M; Migneco, A; Montebelli, R; Ojetti, V; Savi, L; Specchia, L1
de Boer, WA; Kuipers, EJ; Kusters, JG1
Calvet, X; Gené, E; Güell, M; Montserrat, A; Vergara, M1
Candelli, M; Carloni, E; Cazzato, A; Di Campli, C; Fini, L; Gasbarrini, A; Gasbarrini, G; Nista, EC; Pignataro, G; Zocco, MA1
Filik, L; Köksal, AS; Odemiş, B; Ozden, A; Parlak, E; Sahin, B; Saşmaz, N; Ulker, A; Yolcu, OF1
Calvet, X; Gisbert, JP; Gonzalez, L1
Almeida, JR; Campos, LT; Guerrazzi, F; Lorena, SL; Mesquita, MA; Montes, CG; Zeitune, JM1
Donovan, JL; Egger, M; Harvey, IM; Harvey, RF; Lane, JA; Murray, LJ; Nair, P; Noble, S1
Akarca, US; Aydin, A; Musoğlu, A; Onder, GF; Tekin, F; Tunçyürek, M1
Lule, GN1
Lee, KH; Tam, YH; Yeung, CK1
Buzás, GM; Széles, I1
Cakal, B; Kiliç, ZM; Köksal, AS; Kuran, S; Nadir, I; Ozin, YO; Sahin, B1
Ran, ZH; Shen, J; Tong, JL; Xiao, SD1
Demir, M; Gokturk, HS; Ozturk, NA; Serin, E; Yilmaz, U1
Hibi, T; Nishizawa, T; Suzuki, H1
Astegiano, M; Cisarò, F; De Angelis, C; Pellicano, R; Rizzetto, M; Saracco, G1
Ateş, Y; Avşar, E; Aytuğ, N; Bektaş, A; Bölükbaş, C; Dinçer, D; Ellidokuz, E; Erzin, Y; Güliter, S; Kaymakoğlu, S; Kocakaya, O; Onuk, MD; Poturoğlu, S; Taşan, G; Tiftikçi, A; Türkay, C; Yıldırım, B; Yılmaz, U1
Cha, JM; Jeon, JW; Kwak, MS; Yoon, JY1

Reviews

13 review(s) available for ranitidine bismuth citrate and clarithromycin

ArticleYear
Ranitidine bismuth citrate plus clarithromycin for the eradication of H. pylori.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 1997, Volume: 48 Suppl 4

    Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Synergism; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Ranitidine

1997
New options in Helicobacter pylori eradication: efficacy, resistance and synergy.
    Scandinavian journal of gastroenterology. Supplement, 1998, Volume: 225

    Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Ranitidine

1998
Review article: one-week clarithromycin triple therapy regimens for eradication of Helicobacter pylori.
    Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:9

    Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Proton Pump Inhibitors; Ranitidine

1998
Review article: treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based triple therapies.
    Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:8

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Penicillins; Proton Pump Inhibitors; Ranitidine; Treatment Outcome

2000
Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy.
    Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:9

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine

2000
Ranitidine bismuth citrate.
    Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2001, Volume: 15, Issue:6

    Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter pylori; Humans; Peptic Ulcer; Ranitidine

2001
Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.
    Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:6

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Histamine H2 Antagonists; Humans; Metronidazole; Patient Care Planning; Penicillins; Proton Pumps; Ranitidine; Recurrence

2002
Treatment options for patients with Helicobacter pylori infection resistant to one or more eradication attempts.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2003, Volume: 35, Issue:8

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Ranitidine

2003
Sequential therapy; a new treatment for Helicobacter pylori infection. But is it ready for general use?
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2004, Volume: 36, Issue:5

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Ranitidine; Tetracycline

2004
Treatment of H. pylori infection: a review.
    Current medicinal chemistry, 2005, Volume: 12, Issue:4

    Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bismuth; Clarithromycin; Fluoroquinolones; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Macrolides; Ofloxacin; Polypharmacy; Ranitidine; Rifabutin

2005
Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication.
    Helicobacter, 2005, Volume: 10, Issue:3

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine

2005
Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis.
    Journal of clinical pharmacy and therapeutics, 2009, Volume: 34, Issue:1

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Proton Pump Inhibitors; Ranitidine; Tinidazole; Treatment Outcome

2009
Helicobacter pylori eradication therapy.
    Future microbiology, 2010, Volume: 5, Issue:4

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Guidelines as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Proton Pump Inhibitors; Ranitidine; Tetracycline; Treatment Failure; Treatment Outcome

2010

Trials

65 trial(s) available for ranitidine bismuth citrate and clarithromycin

ArticleYear
Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group.
    Alimentary pharmacology & therapeutics, 1996, Volume: 10, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Patient Compliance; Ranitidine; Recurrence

1996
Ranitidine bismuth citrate and clarithromycin twice daily in the eradication of Helicobacter pylori.
    Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:1

    Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Patient Compliance; Ranitidine

1997
Ranitidine bismuth citrate with clarithromycin for the treatment of duodenal ulcer.
    Gut, 1997, Volume: 41, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Life Tables; Male; Middle Aged; Ranitidine; Treatment Outcome; Wound Healing

1997
A new 1-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus two antibiotics.
    Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:4

    Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Pyloric Antrum; Ranitidine

1997
Seven-day treatment for Helicobacter pylori infection: ranitidine bismuth citrate plus clarithromycin and tetracycline hydrochloride.
    Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:4

    Topics: Adult; Aged; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Ranitidine; Tetracycline

1997
Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance.
    The American journal of gastroenterology, 1998, Volume: 93, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Metronidazole; Omeprazole; Penicillins; Placebos; Proton Pump Inhibitors; Ranitidine; Tetracycline

1998
Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers.
    The American journal of gastroenterology, 1998, Volume: 93, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antitrichomonal Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Ranitidine; Treatment Outcome

1998
Ranitidine bismuth citrate plus clarithromycin 7-day regimen is effective in eradicating Helicobacter pylori in patients with duodenal ulcer.
    Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:5

    Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Ranitidine

1998
Ranitidine bismuth citrate with clarithromycin versus omeprazole with amoxycillin in the cure of Helicobacter pylori infection.
    Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:6

    Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Wound Healing

1997
Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
    The American journal of gastroenterology, 1998, Volume: 93, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Penicillins; Ranitidine; Stomach Ulcer; Tetracycline; Treatment Outcome

1998
Efficacy and safety of three 7-day Helicobacter pylori eradication regimens containing ranitidine bismuth citrate.
    Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Penicillins; Ranitidine; Tinidazole

1998
One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin.
    Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:6

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prospective Studies; Ranitidine; Tinidazole

1998
Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer.
    Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:1

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Protocols; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Ranitidine; Single-Blind Method

1998
Ranitidine bismuth citrate with either clarithromycin 1 g/day or 1.5 g/day is equally effective in the eradication of H. pylori and healing of duodenal ulcer.
    Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Child; Child, Preschool; Clarithromycin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Ranitidine

1998
One-week triple therapy with ranitidine bismuth citrate, clarithromycin and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycin for Helicobacter pylori infection: a randomized, clinical trial.
    The American journal of gastroenterology, 1998, Volume: 93, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Ranitidine; Time Factors; Treatment Failure

1998
One-week use of ranitidine bismuth citrate, amoxycillin and clarithromycin for the treatment of Helicobacter pylori-related duodenal ulcer.
    Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:8

    Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Combined Modality Therapy; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Proton Pumps; Ranitidine; Single-Blind Method; Treatment Outcome

1998
Ranitidine bismuth citrate plus clarithromycin: a dual therapy regimen for patients with duodenal ulcer.
    Helicobacter, 1998, Volume: 3, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Ranitidine; Recurrence; Treatment Outcome

1998
High Helicobacter pylori eradication rate with a 1-week regimen containing ranitidine bismuth citrate.
    Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:11

    Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Confidence Intervals; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Ranitidine

1998
Optimal duration of therapy combining ranitidine bismuth citrate with clarithromycin and metronidazole in the eradication of Helicobacter pylori infection.
    Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:1

    Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Ranitidine; Treatment Outcome; Urea

1999
The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection.
    Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:3

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Penicillins; Ranitidine; Stomach Ulcer

1999
Effectiveness of ranitidine bismuth citrate, clarithromycin, and metronidazole therapy for treating Helicobacter pylori.
    The American journal of gastroenterology, 1999, Volume: 94, Issue:4

    Topics: Adult; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Ranitidine; Time Factors

1999
Efficacy of a 1-week regimen of ranitidine bismuth citrate in combination with metronidazole and clarithromycin for Helicobacter pylori eradication.
    Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:4

    Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Ranitidine

1999
Ten-day triple therapy with ranitidine bismuth citrate, amoxicillin, and clarithromycin in eradicating Helicobacter pylori.
    The American journal of gastroenterology, 1999, Volume: 94, Issue:5

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Penicillins; Ranitidine; Urea

1999
Twice-daily versus thrice-daily clarithromycin in combination with ranitidine bismuth citrate in the eradication of Helicobacter pylori.
    Helicobacter, 1999, Volume: 4, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Ranitidine

1999
Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen.
    Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Ranitidine; Treatment Outcome

1999
Comparison of ranitidine bismuth citrate plus clarithromycin with omeprazole plus clarithromycin for the eradication of Helicobacter pylori.
    Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Combinations; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Proton Pump Inhibitors; Ranitidine

1999
One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study.
    Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:8

    Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Combinations; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Penicillins; Peptic Ulcer; Prospective Studies; Ranitidine; Treatment Outcome

1999
Low efficacy of ranitidine bismuth citrate plus clarithromycin combination on Helicobacter pylori in a Turkish population.
    The American journal of gastroenterology, 1999, Volume: 94, Issue:10

    Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Ranitidine; Turkey

1999
Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole.
    Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:10

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Ranitidine; Tetracycline; Treatment Failure

1999
Six-day or seven-day regimens with ranitidine bismuth citrate plus high-dose clarithromycin and tinidazole are both effective against Helicobacter pylori infection.
    Digestive diseases and sciences, 1999, Volume: 44, Issue:12

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Ranitidine; Tinidazole; Treatment Outcome; Urea

1999
Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection.
    Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:1

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Penicillins; Prospective Studies; Ranitidine; Tinidazole; Urea

2000
Efficacy of a multistep strategy for Helicobacter pylori eradication.
    Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:1

    Topics: Algorithms; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Penicillins; Ranitidine; Tinidazole; Treatment Failure

2000
Salvage therapies after failure of Helicobacter pylori eradication with ranitidine bismuth citrate-based therapies.
    Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:1

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Prospective Studies; Proton Pump Inhibitors; Ranitidine; Salvage Therapy

2000
Seven-day triple therapy with ranitidine bismuth citrate or omeprazole and two antibiotics for eradication of Helicobacter pylori in duodenal ulcer: a multicentre, randomized, single-blind study.
    Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Prospective Studies; Ranitidine; Single-Blind Method

2000
Ranitidine bismuth citrate and clarithromycin, alone or in combination, for eradication of Helicobacter mustelae infection in ferrets.
    American journal of veterinary research, 1999, Volume: 60, Issue:10

    Topics: Animals; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Ferrets; Gastric Mucosa; Helicobacter; Helicobacter Infections; Ovariectomy; Ranitidine; Time Factors

1999
The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori.
    Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:7

    Topics: Adult; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Ranitidine; Treatment Outcome

2000
[Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
    Orvosi hetilap, 2000, Jul-30, Volume: 141, Issue:31

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Treatment Outcome

2000
Helicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimen.
    Alimentary pharmacology & therapeutics, 2000, Volume: 14, Issue:10

    Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Costs and Cost Analysis; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Proton Pump Inhibitors; Ranitidine; Treatment Outcome

2000
Ranitidine bismuth citrate can help to overcome Helicobacter pylori resistance to clarithromycin in vivo.
    Helicobacter, 2000, Volume: 5, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Synergism; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Ranitidine

2000
One-week ranitidine bismuth citrate-based triple therapy for the eradication of Helicobacter pylori in Hong Kong with high prevalence of metronidazole resistance.
    Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Hong Kong; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prevalence; Ranitidine; Treatment Outcome; Urea

2001
Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
    The American journal of gastroenterology, 2001, Volume: 96, Issue:5

    Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Patient Compliance; Penicillins; Ranitidine; Veterans

2001
Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study.
    Clinical therapeutics, 2001, Volume: 23, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Headache; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pruritus; Ranitidine; Recurrence; Taste Disorders; Tinidazole; Treatment Outcome

2001
Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy?
    Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:7

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Benzimidazoles; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Ranitidine; Recurrence; Sulfoxides; Tinidazole; Treatment Outcome; Urea

2001
High efficacy of ranitidine bismuth citrate, amoxicillin, clarithromycin and metronidazole twice daily for only five days in Helicobacter pylori Eradication.
    Helicobacter, 2001, Volume: 6, Issue:2

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Ranitidine

2001
Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori.
    Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:8

    Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Ranitidine; Treatment Outcome; Urea; Urease

2001
[Comparative study of the eradication of Helicobacter pylori: ranitidine bismuth citrate versus omeprazole plus two antibiotics for seven days].
    Anales de medicina interna (Madrid, Spain : 1984), 2001, Volume: 18, Issue:7

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine

2001
Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.
    Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:9

    Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Ranitidine; Treatment Outcome

2001
Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia.
    European journal of gastroenterology & hepatology, 2001, Volume: 13, Issue:11

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Penicillins; Peptic Ulcer; Ranitidine; Retrospective Studies

2001
Two new treatment regimens for Helicobacter pylori eradication: a randomised study.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2001, Volume: 33, Issue:8

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Tinidazole; Treatment Outcome

2001
The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
    Wiener klinische Wochenschrift, 2002, Jun-28, Volume: 114, Issue:12

    Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Ranitidine; Treatment Outcome

2002
Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2002, Volume: 85, Issue:10

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Prospective Studies; Ranitidine; Stomach; Thailand; Treatment Outcome

2002
Comparison of three triple regimens with omeprazole or ranitidine bismuth citrate for Helicobacter pylori eradication.
    Scandinavian journal of gastroenterology, 2002, Volume: 37, Issue:12

    Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Patient Compliance; Ranitidine; Tetracycline

2002
A randomized trial comparing seven-day ranitidine bismuth citrate and clarithromycin dual therapy to seven-day omeprazole, clarithromycin and amoxicillin triple therapy for the eradication of Helicobacter pylori.
    Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2003, Volume: 17, Issue:9

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Satisfaction; Ranitidine; Time Factors; Urea

2003
Role of antibiotic sensitivity testing before first-line Helicobacter pylori eradication treatments.
    Alimentary pharmacology & therapeutics, 2003, Oct-15, Volume: 18, Issue:8

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Ranitidine; Tinidazole; Treatment Outcome

2003
Eradication of Helicobacter pylori infection improves blood pressure values in patients affected by hypertension.
    Helicobacter, 2003, Volume: 8, Issue:6

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Proteins; Bismuth; Blood Pressure; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hypertension; Male; Middle Aged; Prevalence; Ranitidine

2003
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
    European journal of gastroenterology & hepatology, 2004, Volume: 16, Issue:10

    Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pilot Projects; Ranitidine; Tetracycline; Treatment Outcome

2004
Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Journal of gastroenterology and hepatology, 2005, Volume: 20, Issue:4

    Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Tetracycline; Treatment Outcome; Turkey

2005
One-week dual therapy with ranitidine bismuth citrate and clarithromycin for the treatment of Helicobacter pylori infection in Brazilian patients with peptic ulcer.
    World journal of gastroenterology, 2005, Jun-21, Volume: 11, Issue:23

    Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Brazil; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Ranitidine; Treatment Outcome

2005
Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial.
    BMJ (Clinical research ed.), 2006, Jan-28, Volume: 332, Issue:7535

    Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Costs and Cost Analysis; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Screening; Middle Aged; Patient Acceptance of Health Care; Peptic Ulcer; Quality of Life; Ranitidine

2006
Seven-day is more effective than 4-day ranitidine bismuth citrate-based triple therapy in eradication of Helicobacter pylori in children: a prospective randomized study.
    Alimentary pharmacology & therapeutics, 2006, Jul-01, Volume: 24, Issue:1

    Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Child; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Peptic Ulcer; Prospective Studies; Ranitidine

2006
Interpretation of the 13C-urea breath test in the choice of second- and third-line eradication of Helicobacter pylori infection.
    Journal of gastroenterology, 2008, Volume: 43, Issue:2

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Infective Agents; Bismuth; Breath Tests; Clarithromycin; Cross-Over Studies; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Urea

2008
Moxifloxacine plus amoxicillin and ranitidine bismuth citrate or esomeprazole triple therapies for Helicobacter pylori infection.
    Digestive diseases and sciences, 2008, Volume: 53, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Aza Compounds; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Humans; Male; Middle Aged; Moxifloxacin; Pilot Projects; Prospective Studies; Quinolines; Ranitidine; Treatment Outcome; Young Adult

2008
Efficacy of two different Helicobacter pylori eradication regimens in patients with type 2 diabetes and the effect of Helicobacter pylori eradication on dyspeptic symptoms in patients with diabetes: a randomized controlled study.
    The American journal of the medical sciences, 2009, Volume: 338, Issue:6

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Pantoprazole; Ranitidine

2009
A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2013, Volume: 24, Issue:4

    Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Endoscopy, Digestive System; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Ranitidine; Treatment Outcome; Young Adult

2013
Pretreatment with Ranitidine Bismuth Citrate May Improve Success Rates of Helicobacter pylori Eradication: A Prospective, Randomized, Controlled and Open-Label Study.
    The Tohoku journal of experimental medicine, 2021, Volume: 255, Issue:1

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacterial Load; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Prospective Studies; Ranitidine; Treatment Failure; Treatment Outcome

2021

Other Studies

15 other study(ies) available for ranitidine bismuth citrate and clarithromycin

ArticleYear
Practice guidelines for treatment of peptic ulcer disease.
    JAMA, 1996, Oct-09, Volume: 276, Issue:14

    Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Peptic Ulcer; Practice Guidelines as Topic; Ranitidine

1996
The role of ranitidine bismuth citrate in significantly reducing the emergence of Helicobacter pylori strains resistant to antibiotics.
    Helicobacter, 1997, Volume: 2, Issue:1

    Topics: Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Interactions; Drug Resistance, Microbial; Helicobacter pylori; Histamine H2 Antagonists; Metronidazole; Ranitidine; Streptomycin

1997
[Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)].
    Revue medicale de Liege, 1998, Volume: 53, Issue:1

    Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Combinations; Duodenal Ulcer; Gastric Acid; Gastric Mucosa; Helicobacter pylori; Histamine H2 Antagonists; Humans; Nitroimidazoles; Penicillins; Proton Pump Inhibitors; Ranitidine; Receptors, Histamine H2; Stomach Ulcer

1998
Ranitidine bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infection.
    Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:2

    Topics: Adult; Aged; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Prospective Studies; Ranitidine; Tetracycline

1999
In vitro synergy between ranitidine bismuth citrate and tetracycline or clarithromycin against resistant strains of Helicobacter pylori.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1999, Volume: 18, Issue:11

    Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Synergism; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Ranitidine; Tetracycline

1999
Effects of in vitro antibiotic resistance on treatment: bismuth-containing regimens.
    Canadian journal of gastroenterology = Journal canadien de gastroenterologie, 2000, Volume: 14, Issue:10

    Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Organometallic Compounds; Ranitidine; Salicylates

2000
Dual therapy with ranitidine bismuth citrate for Helicobacter pylori eradication.
    Journal of clinical gastroenterology, 2001, Volume: 32, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Middle Aged; Peptic Ulcer; Ranitidine

2001
A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxicillin or a nitroimidazole.
    Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:5

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Costs; Drug Resistance; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Patient Care Planning; Penicillins; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine; Treatment Outcome

2001
In search of the Holy Grail of Heliocobacter pylori remedies.
    Helicobacter, 2001, Volume: 6, Issue:2

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Helicobacter Infections; Humans; Metronidazole; Pilot Projects; Ranitidine; Spain

2001
Efficacy of Helicobacter pylori eradication therapies: a single centre observational study.
    BMC gastroenterology, 2001, Volume: 1

    Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Nitroimidazoles; Ranitidine; Treatment Outcome

2001
Helicobacter pylori.
    The New England journal of medicine, 2003, Jan-23, Volume: 348, Issue:4

    Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Ranitidine

2003
Therapeutic efficacy of ranitidine bismuth citrate with clarithromycin for seven days in the eradication of Helicobacter pylori in Brazilian peptic ulcer patients.
    Sao Paulo medical journal = Revista paulista de medicina, 2003, Jan-02, Volume: 121, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Brazil; Clarithromycin; Cross-Sectional Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Peptic Ulcer; Ranitidine

2003
The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2005, Volume: 16, Issue:4

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Polymerase Chain Reaction; Ranitidine; Treatment Outcome

2005
Helicobacter pylori eradication in peptic dyspepsia.
    East African medical journal, 2005, Volume: 82, Issue:12

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine

2005
Ranitidine bismuth citrate in the first-line of Helicobacter pylori treatment.
    Panminerva medica, 2011, Volume: 53, Issue:2

    Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Ranitidine; Treatment Outcome

2011